Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-20-005387
Filing Date
2020-09-14
Accepted
2020-09-14 16:50:14
Documents
83
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ipix_10k.htm 10-K 1133817
2 CONSENT ipix_ex231.htm EX-23.1 1975
3 CERTIFICATION ipix_ex311.htm EX-31.1 9629
4 CERTIFICATION ipix_ex321.htm EX-32.1 4093
  Complete submission text file 0001477932-20-005387.txt   6147886

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ipix-20200630.xml EX-101.INS 985003
6 XBRL TAXONOMY EXTENSION SCHEMA ipix-20200630.xsd EX-101.SCH 96397
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20200630_lab.xml EX-101.LAB 491045
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20200630_cal.xml EX-101.CAL 52623
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20200630_pre.xml EX-101.PRE 462086
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20200630_def.xml EX-101.DEF 335061
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

EIN.: 300565645 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-37357 | Film No.: 201173679
SIC: 2834 Pharmaceutical Preparations